Why the study?
Little progress has been made in diagnosing or preventing perioperative AKI, partly due to late detection by conventional criteria based on functional biomarkers, serum creatinine, and urine output.
Do damage biomarkers and timely perioperative management improve the early detection and prevention of perioperative acute kidney injury compared to conventional functional biomarkers?
Do damage biomarkers and timely perioperative management improve the early detection and prevention of perioperative acute kidney injury compared to conventional functional biomarkers?
Answers are grounded in this paper and cite their sources.
Damage biomarkers enable earlier detection of perioperative AKI than conventional criteria, allowing for timely preventive interventions such as optimizing volume status and perfusion.
PURPOSE OF REVIEW: Acute kidney injury (AKI) is underestimated but common in the perioperative setting. Although the association of this syndrome with an increased morbidity and mortality has been well established, little progress has been made in the diagnosis or prevention of AKI in recent years. This is partly due to the late detection of AKI by conventional criteria based of functional biomarkers, serum creatinine, and urine output. In addition, conceptually AKI is now recognized as being part of a continuum, in which preventive intervention is time critical. This review will summarize the current best available evidence and explain why timely perioperative management does have impact on the development of AKI and overall outcomes for patients. RECENT FINDINGS: Damage biomarkers can reliably identify AKI earlier than conventional functional biomarkers, facilitating more timely preventive intervention. Although the interventions published in the Kidney Disease: Improving Global Outcomes guideline are all important, the most relevant preventive options perioperatively include maintenance of adequate volume status and perfusion pressure, and the focus on balanced crystalloid solutions as maintenance fluid. SUMMARY: AKI is a time critical syndrome that requires timely detection and damage biomarkers can help to adjust the perioperative management to prevent further injury.
No takes yet. Share an insight, caveat, or question.
Saadat-Gilani et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: